Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma

Hisateru Komatsu1,2, Tomohiro Iguchi1, Takaaki Masuda1

  • 1Department of Surgery, Kyushu University Beppu Hospital, Beppu, Japan.

Abstract

Insights

Reduced RND1 gene expression in hepatocellular carcinoma (HCC) correlates with poorer prognosis and increased cancer progression. This suggests RND1 may be a novel biomarker for predicting patient outcomes in HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RND1 gene encodes a Rho GTPase family protein crucial for cellular functions.
  • Decreased RND1 expression is linked to the activation of the oncogenic Ras signaling pathway.
  • Hepatocellular carcinoma (HCC) progression involves complex genetic and signaling alterations.

Purpose of the Study:

  • To determine the clinical significance of RND1 expression in predicting prognosis for HCC patients.
  • To elucidate the biological role of RND1 in the development and progression of human HCC.
  • To investigate the relationship between RND1 and the Ras signaling pathway in HCC.

Main Methods:

  • Analysis of RND1 expression and clinical outcomes in three independent HCC cohorts (n=692).
  • Gene Set Enrichment Analysis (GSEA) to assess pathway correlations.
  • In vitro knockdown experiments using small interfering RNA (siRNA) in HCC cells.

Main Results:

  • RND1 expression decreased with HCC progression and was influenced by promoter methylation.
  • Low RND1 expression was significantly associated with poorer overall survival (OS) and recurrence-free survival.
  • RND1 expression showed an inverse correlation with Ras signaling activity; RND1 knockdown increased HCC cell proliferation, invasion, and chemoresistance.

Conclusions:

  • Reduced RND1 expression in HCC is linked to cancer progression, potentially via Ras signaling pathway regulation.
  • RND1 expression serves as an independent prognostic factor for OS in HCC.
  • RND1 may represent a novel clinical biomarker for predicting HCC patient prognosis.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K